Feedback / Questions
Ivesa (firmonertinib) - Allist, ArriVent
https://www.globenewswire.com/news-release/2025/06/23/3103248/0/en/ArriVent-Announces-Positive-Interim-Firmonertinib-Monotherapy-Data-From-Global-Phase-1b-Study-in-EGFR-PACC-Mutant-Non-Small-Cell-Lung-Cancer-and-Plans-to-Advance-into-a-Global-Pivo.html
Jun 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next